The Link between an Epidermal Growth Factor Gene Functional Polymorphism and Hepatocellular Carcinoma in a Cohort of Hepatitis C Egyptian Patients

Bibliographic Information
Authors: Madkour B.A.; Mahmoud O.M.; Nil O.B.A.E.; Aboul-Ezz M.A.; Morsy S.A.; Mashaal A.R.; Sabry O.M.
Journal: Egyptian Journal of Hospital Medicine
Publisher: Ain Shams University Faculty of Medicine
Publication Date: 1 October 2022
Volume / Issue: Volume 89 / Issue 1
Pages: 5860–5864
ISSN: 16872002
DOI: 10.21608/ejhm.2022.266660
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access
Authors and Affiliations
Madkour B.A., Hematology Department, Theodor Bilharz Research Institute, Giza, Egypt; Mahmoud O.M., Hematology Department, Theodor Bilharz Research Institute, Giza, Egypt; Nil O.B.A.E., Hematology Department, Theodor Bilharz Research Institute, Giza, Egypt; Aboul-Ezz M.A., Hepato-gastroenterology Department, Theodor Bilharz Research Institute, Giza, Egypt; Morsy S.A., Hepato-gastroenterology Department, Theodor Bilharz Research Institute, Giza, Egypt; Mashaal A.R., Hepato-gastroenterology Department, Theodor Bilharz Research Institute, Giza, Egypt; Sabry O.M., Hematology Department, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Background: Chronic hepatitis C (HCV) infection is implicated in hepatocarcinogenesis. Hepatocellular carcinoma (HCC) progression is influenced by a number of genetic and epigenetic mechanisms. One of the most critical variables in early hepatocarcinogenesis is the dysregulation of the epidermal growth factor receptor (EGFR) or the epidermal growth factor (EGF) signaling pathway. This study aimed to assess the association between the incidence of HCC and the EGF 61A/G polymorphism in chronic HCV Egyptian cases. Patients and methods: A comparative study was carried out with a total of 165 single ethnic Egyptian. They were classified into 3 groups: Chronic HCV (n = 55), HCC (n = 60), and healthy cases (n = 50). Genotyping was performed for all participants using RT-Multiplex PCR. Results: The frequencies of genotypes were in HCV G/A 32.7%, G/G 60.0%, and A/A 7.3%, and in HCC G/A 51.7%, G/G 30.0%, and A/A 18.3%. The control group was G/A 52.0%, G/G 20.0%, and A/A 28.0%. The alleles frequencies in HCV were G 76.4%, and A 23.6%, in HCC were G 55.8% and A 44.2%. In the control group were G 46.0% and A 54.0%. The difference regarding the genotype and allele frequency among studied groups was highly significant. The G/G genotype (P-value 0.006) were protective against HCC development. However, HCV patients with the A/G genotype (P-value 0.04) might be at a higher risk to develop HCC. Conclusion: The indications for EGF 61A/G gene polymorphism's correlation with susceptible threat for HCC development in HCV patients in Egypt. © 2022, Ain Shams University Faculty of Medicine. All rights reserved.
Keywords
Comparative study; EGF 61A/G gene polymorphism; HCC; HCV; Theodor Bilharz Research Institute
Citation Information
Scopus Citations: 1
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
